Warner Chilcott Hits Watson With Atelvia Patent Suit
Watson Pharmaceuticals Inc. confirmed Monday that Warner Chilcott LLC has launched a patent suit in New Jersey seeking to stop the company from marketing a generic version of the postmenopausal osteoporosis...To view the full article, register now.
Already a subscriber? Click here to view full article